BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6501940)

  • 1. Antiproliferative activity of human interferons against ovarian cancer cells grown in human tumor stem cell assay.
    Willson JK; Bittner G; Borden EC
    J Interferon Res; 1984; 4(4):441-7. PubMed ID: 6501940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cloned human leukocyte interferons in the human tumor stem cell assay.
    Salmon SE; Durie BG; Young L; Liu RM; Trown PW; Stebbing N
    J Clin Oncol; 1983 Mar; 1(3):217-25. PubMed ID: 6686847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay.
    Schiller JH; Willson JK; Bittner G; Wolberg WH; Hawkins MJ; Borden EC
    J Interferon Res; 1986 Dec; 6(6):615-25. PubMed ID: 2437222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay.
    Higashihara J; Saito T; Berens ME; Welander CE
    Cancer Chemother Pharmacol; 1988; 22(3):215-22. PubMed ID: 3136942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta.
    Johns TG; Mackay IR; Callister KA; Hertzog PJ; Devenish RJ; Linnane AW
    J Natl Cancer Inst; 1992 Aug; 84(15):1185-90. PubMed ID: 1378904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral-acting benzodiazepines inhibit the growth of human melanoma cells and potentiate the antiproliferative activity of recombinant human interferons.
    Solowey WE; Pestka S; Spector S; Fryer RI; Fisher PB
    J Interferon Res; 1990 Jun; 10(3):269-80. PubMed ID: 1696606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented antiproliferative effects of interferons at elevated temperatures against human bladder carcinoma cell lines.
    Groveman DS; Borden EC; Merritt JA; Robins HI; Steeves R; Bryan GT
    Cancer Res; 1984 Dec; 44(12 Pt 1):5517-21. PubMed ID: 6498814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative assay of human leucocyte interferon.
    Hirai N; Hattori N; Hill NO; Osther K
    Tohoku J Exp Med; 1987 Mar; 151(3):309-16. PubMed ID: 3035749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of human natural interferon-alpha and mismatched double-stranded RNA against a human renal cell carcinoma xenograft.
    Hubbell HR; Pequignot EC; Shanabrook KR; Carter WA; Williams RD; Strayer DR
    Anticancer Res; 1990; 10(3):795-801. PubMed ID: 2369093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of recombinant human interferon-alpha, beta and gamma on the antiproliferative activity of cytarabine in K562 human myeloid leukemia clonogenic cells.
    Hassan HT; Tsiriyotis C; Maurer HR
    Hematol Oncol; 1992; 10(2):117-24. PubMed ID: 1592362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent].
    Ohmura K; Tsukamoto T
    Hinyokika Kiyo; 1989 May; 35(5):737-47. PubMed ID: 2801371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells.
    Fish EN; Banerjee K; Stebbing N
    Biochem Biophys Res Commun; 1983 Apr; 112(2):537-46. PubMed ID: 6303322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
    Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
    J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro comparative study of the antitumor effects of human interferon-alpha, beta and gamma on the growth and invasive potential of human melanoma cells.
    Horikoshi T; Fukuzawa K; Hanada N; Ezoe K; Eguchi H; Hamaoka S; Tsujiya H; Tsukamoto T
    J Dermatol; 1995 Sep; 22(9):631-6. PubMed ID: 8537547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative effects of interferon-alphaCon1 on ovarian clear cell adenocarcinoma in vitro and in vivo.
    Takemoto Y; Yano H; Momosaki S; Ogasawara S; Nishida N; Kojiro S; Kamura T; Kojiro M
    Clin Cancer Res; 2004 Nov; 10(21):7418-26. PubMed ID: 15534119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of in vitro antiproliferation activity of human interferon-beta.
    Kataoka T; Oh-hashi F; Sakurai Y; Ida N
    Cancer Chemother Pharmacol; 1982; 9(2):75-80. PubMed ID: 7172408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD; Fang H; Xu J; Grimley PM; Rui H
    Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antiproliferative activities of IFNs alpha, beta and gamma: kinetics of establishment of their antiproliferative effects and the rapid development of resistance to IFNs alpha and beta.
    Fleischmann CM; Fleischmann WR
    J Biol Regul Homeost Agents; 1988; 2(4):173-85. PubMed ID: 3150645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative effect of interferons on human prostate carcinoma cell lines.
    Sica G; Fabbroni L; Castagnetta L; Cacciatore M; Pavone-Macaluso M
    Urol Res; 1989; 17(2):111-5. PubMed ID: 2734978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antiproliferative effect of recombinant alpha-interferons with recombinant gamma-interferon.
    Hubbell HR; Craft JA; Leibowitz PJ; Gillespie DH
    J Biol Response Mod; 1987 Apr; 6(2):141-53. PubMed ID: 3108460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.